670
Views
5
CrossRef citations to date
0
Altmetric
Original Article

Association of anti-Ro/SSA antibody with response to biologics in patients with rheumatoid arthritis

, , , , , , , , , , , , , , , , , , & show all
Pages 857-862 | Received 09 Dec 2015, Accepted 08 Feb 2016, Published online: 22 Mar 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Y Endo, T Koga, S-y Kawashiri, S Morimoto, A Nishino, M Okamoto, S Tsuji, A Takatani, T Shimizu, R Sumiyoshi, T Igawa, N Iwamoto, K Ichinose, M Tamai, H Nakamura, T Origuchi, Y Ueki, T Yoshitama, N Eiraku, N Matsuoka, A Okada, K Fujikawa, H Hamada, T Tsuru, S Nagano, Y Arinobu, T Hidaka, Y Tada & A Kawakami. (2021) Significance of anti-Ro/SSA antibodies in the response and retention of abatacept in patients with rheumatoid arthritis: a multicentre cohort study. Scandinavian Journal of Rheumatology 50:1, pages 15-19.
Read now

Articles from other publishers (4)

Hiroto Tsuboi, Hirofumi Toko, Fumika Honda, Saori Abe, Hiroyuki Takahashi, Mizuki Yagishita, Shinya Hagiwara, Ayako Ohyama, Yuya Kondo, Kazuhisa Nakano, Yoshiya Tanaka, Toshimasa Shimizu, Hideki Nakamura, Atsushi Kawakami, Yuichiro Fujieda, Tatsuya Atsumi, Yasunori Suzuki, Mitsuhiro Kawano, Naoshi Nishina, Yuko Kaneko, Tsutomu Takeuchi, Hitomi Kobayashi, Masami Takei, Michihiro Ogasawara, Naoto Tamura, Yoshinari Takasaki, Kazuhiro Yokota, Yuji Akiyama, Toshihide Mimura, Kosaku Murakami, Tsuneyo Mimori, Shiro Ohshima, Naoto Azuma, Hajime Sano, Susumu Nishiyama, Isao Matsumoto & Takayuki Sumida. (2023) Abatacept ameliorates both glandular and extraglandular involvements in patients with Sjögren’s syndrome associated with rheumatoid arthritis: Findings from an open-label, multicentre, 1-year, prospective study: The ROSE (Rheumatoid Arthritis with Orencia Trial Toward Sjögren’s Syndrome Endocrinopathy) and ROSE II trials. Modern Rheumatology 33:1, pages 160-168.
Crossref
Ayano Mori, Toshiharu Saito, Miho Takahashi, Miho Shibata, Goh Tsuji, Saori Hatachi, Soshi Takahashi & Shunichi Kumagai. (2020) Presence of anti-nuclear antibodies is a risk factor for the appearance of anti-drug antibodies during infliximab or adalimumab therapy in patients with rheumatoid arthritis. PLOS ONE 15:12, pages e0243729.
Crossref
Lucía Lourido, Cristina Ruiz-Romero, Flor Picchi, Naomi Diz-Rosales, Sergio Vilaboa-Galán, Carlos Fernández-López, José Antonio Pinto Tasende, Eva Pérez-Pampín, Cristina Regueiro, Antonio Mera-Varela, Antonio Gonzalez, Karen Hambardzumyan, Saedis Saevarsdottir, Peter Nilsson & Francisco J. Blanco. (2020) Association of serum anti-centromere protein F antibodies with clinical response to infliximab in patients with rheumatoid arthritis: A prospective study. Seminars in Arthritis and Rheumatism 50:5, pages 1101-1108.
Crossref
Divya N. V. Challa, Zoran Kvrgic, Cynthia S. Crowson, Eric L. Matteson, Thomas G. Mason, Clement J. MichetJrJr, Daniel E. Schaffer, Kerry A. Wright & John M. DavisIIIIII. (2019) Longitudinal Occurrence and Predictors of Patient‐Provider Discordance Between Global Assessments of Disease Activity in Rheumatoid Arthritis: A Case–Control Study. Arthritis Care & Research 72:1, pages 18-26.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.